Loading…
Loading…
JNHMF does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for JNHMF and 80,000+ other tickers.
See exactly how JNHMF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for JNHMF and 80,000+ other tickers.
Jack Nathan Medical Corp., together with its associated entities, focuses on operating primary care medical clinics. These facilities, known as Jack Nathan Health, are primarily situated within Walmart Supercentres. As of June 30, 2022, the company's Canadian presence included 76 clinics located inside Walmart stores across various provinces, namely British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec. Additionally, within Canada, it managed 4 clinics independent of Walmart, supplemented by 18 specialized medical clinics, 2 rehabilitation centers, and 5 MedSpa facilities. In…
Toronto, Ontario--(Newsfile Corp. - July 31, 2026) - Jack Nathan Medical Corp. (TSXV: JNH) (OTC Pink: JNHMF) ("Jack Nathan" or the "Company") announces that Blake Lyon, Chairman of the Board of Directors, and Anthony DeCristofaro, Director, have resigned from the Board of Directors of the Company (the "Board"), effective July 31, 2026. Mr. Lyon and Mr.
TORONTO--(BUSINESS WIRE)--Jack Nathan Medical Corp. (TSXV: JNH; Pink Limited: JNHMF) (the “Company”) today announced a leadership transition and strategic alignment designed to support the Company's next phase of growth, balance sheet optimisation, and evaluation of value-enhancing strategic transactions. Mike Marchelletta will be stepping down as Chief Executive Officer and Vice-Chairman, effective immediately, to lead a prospective investor syndicate evaluating a potential strategic transacti.
TORONTO--(BUSINESS WIRE)--Jack Nathan Medical Corp. (TSXV: JNH, OTCID: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three and six months ended July 31, 2025. Jack Nathan Health's financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). Management Commentary Mike Marchelletta, Chief Executive Officer, commented: “Q2 marked the closu.
TORONTO--(BUSINESS WIRE)--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) announced today its unaudited interim consolidated financial results for the first quarter of fiscal 2026, three months ended April 30, 2025. Jack Nathan Health's financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). Management Commentary Mike Marchelletta, Chief Executive Officer, commented: “Q1 represented a transitio.
TORONTO--(BUSINESS WIRE)--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) announced today its audited consolidated annual financial results for the fourth quarter of fiscal 2025, and fiscal year ended January 31, 2025. Jack Nathan Health's financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). Disclosure Regarding Filing Timing As previously disclosed in a press release issued on June 9, 2025,.